
Manjula Upadhyay
About Manjula Upadhyay
Data last updated:
Manjula Upadhyay is a Director at The Delhi Flour Mills Company Limited (since 2024), Director at Panacea Biotec Pharma Limited (since 2021) and Director at Panacea Biotec Pharma Limited (since 2021), and holds 2 more current directorships. The companies operate in Food and Beverages, Pharma and Agriculture. The 4 current companies with reported revenue have a combined latest revenue of ₹1,084 Cr; the largest is The Delhi Flour Mills Company Limited at ₹551 Cr (FY 2025). Earlier, Manjula Upadhyay was a Director at Panacea Biotec Limited (2015–2025) and Director at Newrise Healthcare Private Limited (2015–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Aug 2024 | 1916 | ₹551 Cr (FY 2025) | Active | |
| Director | 23 Jul 2021 | 2019 | ₹265 Cr (FY 2025) | Active | |
| Director | 23 Jul 2021 | 2019 | ₹265 Cr (FY 2025) | Active | |
| Director | 15 Mar 2017 | 1918 | ₹2.31 Cr (FY 2025) | Active | |
| Designated Partner | 17 Apr 2018 | 2018 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 30 Mar 2015 | 1984 | ₹585 Cr (FY 2024) | Active | |
| Director | 03 Sep 2015 | 2002 | ₹2.8 Lakh (FY 2017) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Manjula Upadhyay
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manjula Upadhyay
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manjula Upadhyay
Manjula Upadhyay currently holds 5 directorships: The Delhi Flour Mills Company Limited (Director, since 30 Aug 2024, revenue ₹551 Cr (FY 2025)); Panacea Biotec Pharma Limited (Director, since 23 Jul 2021, revenue ₹265 Cr (FY 2025)); Panacea Biotec Pharma Limited (Director, since 23 Jul 2021, revenue ₹265 Cr (FY 2025)); Dtc India Limited (Director, since 15 Mar 2017, revenue ₹2.31 Cr (FY 2025)); Mr Lex Corp Llp (Designated Partner, since 17 Apr 2018).
Manjula Upadhyay was first appointed on 30 Mar 2015 as Director at Panacea Biotec Limited. The most recent appointment on record is 30 Aug 2024 at The Delhi Flour Mills Company Limited.
The 4 current companies of Manjula Upadhyay that report revenue have a combined latest revenue of ₹1,084 Cr: The Delhi Flour Mills Company Limited ₹551 Cr (FY 2025); Panacea Biotec Pharma Limited ₹265 Cr (FY 2025); Panacea Biotec Pharma Limited ₹265 Cr (FY 2025); Dtc India Limited ₹2.31 Cr (FY 2025).
Manjula Upadhyay held 2 earlier board appointments: Panacea Biotec Limited (Director, 30 Mar 2015 to 29 Mar 2025); Newrise Healthcare Private Limited (Director, 03 Sep 2015 to 19 Apr 2017).
The current boards of Manjula Upadhyay's companies include Brahm Dev Sharma (The Delhi Flour Mills Company Limited), Mohit Jain (The Delhi Flour Mills Company Limited), Mohit Satyanand (The Delhi Flour Mills Company Limited), Mr. Raju Singh Tomer (The Delhi Flour Mills Company Limited), Rajiv Bhambri (The Delhi Flour Mills Company Limited), Rajiv Bhambri (The Delhi Flour Mills Company Limited), among others.